The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
High-resolution serum proteomic features for ovarian cancer detection.
Open accessAbstract
Serum proteomic pattern diagnostics is an emerging paradigm employing low-resolution mass spectrometry (MS) to generate a set of biomarker classifiers. In the present study, we utilized a well-controlled ovarian cancer serum study set to compare the sensitivity and specificity of serum proteomic diagnostic patterns acquired using a high-resolution versus a low-resolution MS platform. In blinded testing sets, the high-resolution mass spectral data contained multiple diagnostic signatures that were superior to the low-resolution spectra in terms of sensitivity and specificity (P<0.00001) throughout the range of modeling conditions. Four mass spectral feature set patterns acquired from data obtained exclusively with the high-resolution mass spectrometer were 100% specific and sensitive in their diagnosis of serum samples as being acquired from either unaffected patients or those suffering from ovarian cancer. Important to the future of proteomic pattern diagnostics is the ability to recognize inferior spectra statistically, so that those resulting from a specific process error are recognized prior to their potentially incorrect (and damaging) diagnosis. To meet this need, we have developed a series of quality-assurance and in-process control procedures to (a) globally evaluate sources of sample variability, (b) identify outlying mass spectra, and (c) develop quality-control release specifications. From these quality-assurance and control (QA/QC) specifications, we identified 32 mass spectra out of the total 248 that showed statistically significant differences from the norm. Hence, 216 of the initial 248 high-resolution mass spectra were determined to be of high quality and were remodeled by pattern-recognition analysis. Again, we obtained four mass spectral feature set patterns that also exhibited 100% sensitivity and specificity in blinded validation tests (68/68 cancer: including 18/18 stage I, and 43/43 healthy). We conclude that (a) the use of high-resolution MS yields superior classification patterns as compared with those obtained with lower resolution instrumentation; (b) although the process error that we discovered did not have a deleterious impact on the present results obtained from proteomic pattern analysis, the major source of spectral variability emanated from mass spectral acquisition, and not bias at the clinical collection site; (c) this variability can be reduced and monitored through the use of QA/QC statistical procedures; (d) multiple and distinct proteomic patterns, comprising low molecular weight biomarkers, detected by high-resolution MS achieve accuracies surpassing individual biomarkers, warranting validation in a large clinical study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holland, J. H. (1992) · The MIT Press eBooks · doi:10.7551/mitpress/1090.001.0001 · Cited by 47,002
Hapeman, D. E. (1991) · Technometrics · doi:10.1080/00401706.1991.10484817 · Cited by 9,373
Kohonen, T. (1990) · Proceedings of the IEEE · doi:10.1109/5.58325 · Cited by 8,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Self-citationFleiss, J. L., & Agresti, A. (1991) · Journal of the American Statistical Association · doi:10.2307/2290537 · Cited by 2,641
Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Self-citationSerum Proteomic Patterns for Detection of Prostate Cancer
Petricoin, E. F. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1576 · Cited by 736
Self-citationRapid Communications in Mass Spectrometry
(2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/(issn)1097-0231 · Cited by 675
New desorption strategies for the mass spectrometric analysis of macromolecules
Hutchens, T. W., & Yip, T. (1993) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290070703 · Cited by 621
Adam, B.-L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., et al. (2002) · PubMed · Cited by 612
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14068-8 · Cited by 602
Clinical proteomics: Written in blood
Liotta, L. A., Ferrari, M., & Petricoin, E. (2003) · Nature · doi:10.1038/425905a · Cited by 534
Self-citationAn investigation into the human serum “interactome”
Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J., Petricoin, E. F., Liotta, L. A., Veenstra, T. D., & Conrads, T. P. (2004) · ELECTROPHORESIS · doi:10.1002/elps.200405866 · Cited by 313
Self-citationCA125 antigen levels in obstetric and gynecologic patients.
Niloff, J. M., KNAPP, R. C., Schaetzl, E., Reynolds, C., & Bast, R. C. (1984) · PubMed · Cited by 271
Zurawski, V. R., Orjaseter, H., Andersen, A., & Jellum, E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420507 · Cited by 268
Biomarker Amplification by Serum Carrier Protein Binding
Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., & Liotta, L. A. (2003) · Disease Markers · doi:10.1155/2003/104879 · Cited by 208
Self-citationCohen, L. S., Escobar, P. F., Scharm, C., Glimco, B., & Fishman, D. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6253 · Cited by 203
Self-citationRecent developments in ovarian cancer screening
Menon, U., & Jacobs, I. J. (2000) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200002000-00007 · Cited by 121
Hensley, M. L. (2002) · Current Treatment Options in Oncology · doi:10.1007/s11864-002-0059-3 · Cited by 43
Cited by
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Villanueva, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26022 · Cited by 741
Aliferis, C., Statnikov, A., Tsamardinos, I., Mani, S., & Koutsoukos, X. (2010) · doi:10.5555/1756006.1756013 · Cited by 469
Issaq, H. J., Xiao, Z., & Veenstra, T. D. (2007) · Chemical Reviews · doi:10.1021/cr068287r · Cited by 315
Self-citationBaggerly, K. A., & Coombes, K. R. (2009) · The Annals of Applied Statistics · doi:10.1214/09-aoas291 · Cited by 312
Metadata
- Authors
- Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., Barrett, J. C., Liotta, L. A., Petricoin, E. F., & Veenstra, T. D.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2004-06
- Volume
- 11
- Issue
- 2
- Pages
- 163-178
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2154639585
- Cited by
- 260
- References
- 20
- FWCI
- 19.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.